cefuroxime has been researched along with Amnionitis in 1 studies
Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.
Excerpt | Relevance | Reference |
---|---|---|
"In an open nonrandomized, dose-response study, nine patients with PROM at 27-33 weeks' gestation received 1." | 1.29 | Achievement of therapeutic concentrations of cefuroxime in early preterm gestations with premature rupture of the membranes. ( Bouckaert, PX; Cremers, HM; De Leeuw, JW; Roumen, FJ; Vree, TB, 1993) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
De Leeuw, JW | 1 |
Roumen, FJ | 1 |
Bouckaert, PX | 1 |
Cremers, HM | 1 |
Vree, TB | 1 |
1 other study available for cefuroxime and Amnionitis
Article | Year |
---|---|
Achievement of therapeutic concentrations of cefuroxime in early preterm gestations with premature rupture of the membranes.
Topics: Adult; Amniotic Fluid; Cefuroxime; Chorioamnionitis; Chromatography, High Pressure Liquid; Dose-Resp | 1993 |